Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takako Murayama is active.

Publication


Featured researches published by Takako Murayama.


Clinical & Experimental Allergy | 1998

Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma

Akio Niimi; Ryouichi Amitani; Katsuhiro Suzuki; Eisaku Tanaka; Takako Murayama; Fumiyuki Kuze

The serum level of eosinophil cationic protein (ECP) has been used as a clinical marker in asthma, on the assumption that it reflects ongoing eosinophilic inflammation of the airways. However, only a few studies have investigated this issue, using bronchial secretions but not tissue specimens.


Thorax | 1998

Effects of Aspergillus fumigatus culture filtrate on antifungal activity of human phagocytes in vitro

Takako Murayama; Ryoichi Amitani; Yumiko Ikegami; Rieko Kawanami; Woon Joo Lee; Ryuhei Nawada

BACKGROUND Aspergillus fumigatus can colonise the airways and the lungs with localised underlying conditions and occasionally invade the surrounding lung tissues even in subjects without systemic predisposing factors, presumably by escaping the local host defences. The aim of this study was to investigate the effects of A fumigatus culture filtrate (ACF) on the activities of human phagocytes—inhibition of germination of A fumigatus spores by alveolar macrophages (AMs) and hyphal damage by polymorphonuclear leucocytes (PMNs)—which are the critical host defences against A fumigatus. METHODS Spores were incubated with AMs at a ratio of 1:1 in a medium containing different concentrations of ACF for 10 hours at 37°C. Spore germination was visualised with light microscopy and the inhibition rate was calculated. The percentage of hyphal damage caused by PMNs pretreated with various concentrations of ACF was measured by a colorimetric tetrazolium metabolic assay. RESULTS The inhibition rate of spore germination by AMs cultured with medium alone (control) was 90 (0.8)% whereas that by AMs cultured with the medium containing 10% ACF was significantly (p<0.05) reduced to 41.7 (4.6)%. ACF suppressed the inhibition of spore germination in a dose dependent manner without altering the phagocytosing activity against the spores. The percentage of hyphal damage caused by PMNs pretreated with medium-199 (control) was 78.1 (2.3)% compared with 65.3 (2.8)% when PMNs were pretreated with 50% ACF (p<0.05). CONCLUSIONS A fumigatusreleases biologically active substance(s) which suppress the inhibition of spore germination by AMs and also suppress PMN mediated hyphal damage, and thus may contribute to the pathogenicity of this fungus.


American Journal of Respiratory and Critical Care Medicine | 1997

Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease.

Eisaku Tanaka; Ryoichi Amitani; Akio Niimi; Katsuhiro Suzuki; Takako Murayama; Fumiyuki Kuze


American Journal of Respiratory and Critical Care Medicine | 1999

Effect of Clarithromycin Regimen for Mycobacterium avium Complex Pulmonary Disease

Eisaku Tanaka; Terumi Kimoto; Kazunari Tsuyuguchi; Isao Watanabe; Hisako Matsumoto; Akio Niimi; Katsuhiro Suzuki; Takako Murayama; Ryoichi Amitani; Fumiyuki Kuze


Clinical Infectious Diseases | 1996

Bronchial Mucoid Impaction Due to the Monokaryotic Mycelium of Schizophyllum commune

Ryoichi Amitani; Kazuko Nishimura; Akio Niimi; Hideki Kobayashi; Ryuhei Nawada; Takako Murayama; Hideaki Taguchi; Fumiyuki Kuze


American Journal of Respiratory and Critical Care Medicine | 2000

Familial pulmonary Mycobacterium avium complex disease.

Eisaku Tanaka; Terumi Kimoto; Hisako Matsumoto; Kazunari Tsuyuguchi; Katsuhiro Suzuki; Sonoko Nagai; Mitsunobu Shimadzu; Hideaki Ishibatake; Takako Murayama; Ryoichi Amitani


Journal of Clinical Microbiology | 1996

Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection.

R Nawada; Ryoichi Amitani; Eisaku Tanaka; Akio Niimi; Kazuo Suzuki; Takako Murayama; F Kuze


The American review of respiratory disease | 1988

Isolation and Partial Characterization of Human Low Molecular Weight Protein Associated with Pulmonary Surfactant

Kumiko Kogishi; Mafumi Kurozumi; Yoko Fujita; Takako Murayama; Fumiyuki Kuze; Yasuhiro Suzuki


American Journal of Respiratory Cell and Molecular Biology | 1993

Lipopolysaccharide primes human alveolar macrophages for enhanced release of superoxide anion and leukotriene B4 : self-limitations of the priming response with protein synthesis

Katsuhiro Suzuki; Takashi Yamamoto; Atsuo Sato; Takako Murayama; Ryouichi Amitani; Kokichi Yamamoto; Fumiyuki Kuze


Clinical and Experimental Immunology | 2008

Recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) or tumour necrosis factor-alpha (TNF-α) activate human alveolar macrophages to inhibit growth of Mycobacterium avium complex

Kazuo Suzuki; Woon Joo Lee; Toru Hashimoto; Eisaku Tanaka; Takako Murayama; Ryouichi Amitani; Kokichi Yamamoto; Fumiyuki Kuze

Collaboration


Dive into the Takako Murayama's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Akio Niimi

Nagoya City University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge